Skip to content
  • The Bactiguard Technology
  • License Partnerships
  • Wound Management
  • Investors

Blog category

April 14, 2025

Consensus report published on Clean to Heal
Hydrocyn aqua® – Advanced Wound Care, Updates14 April 2025

BACTIGUARD AB

Vasagatan 11, 111 20 Stockholm Alfred Nobels Allé 150, 146 48 Tullinge PO Box 15, 146 21 Tullinge, Sweden +46 8 440 58 80 info@bactiguard.com

About Bactiguard

  • Contact
  • About us
  • History
  • Purpose, vision and mission
  • Education
  • Whistleblower

Our business

  • License Partnerships
  • The Bactiguard Technology
  • Clinical evidence
  • Healthcare challenges
  • Education
  • Updates
  • Investors

©2025 Bactiguard AB. All Rights Reserved.

Privacy policy
Cookies
Youtube
LinkedIn
Go to Top
Search
  • License Partnerships
    • Strategic therapeutic areas
  • The Bactiguard Technology
    • Medical devices
      • Implants
        • ZNN™ Bactiguard
      • Intensive care
        • BIP Central Venous Catheter
        • BIP Endotracheal Tube
        • BIP Endotracheal Tube Evac
        • BIP Foley TempSensor
      • Urology
        • BIP Foley Catheter
        • BIP Foley Catheter – Silicone
        • Education
          • Catheter treatment
            • Who needs catheter treatment?
            • Catheter treatment types
            • Which catheter to choose
            • How to catheterize?
            • Documentation
            • Patient care (catheter care)
            • Common complications
            • Definitions
  • Wound Management
    • Hydrocyn Aqua
      • Test results
    • Surgical sutures
    • Menu iconDistributor login
  • Healthcare challenges
    • Antimicrobial resistance (AMR)
    • Biofilm
    • HAI/Medical device related infections
      • Catheter associated urinary tract infection
      • Catheter related bloodstream infection
      • Ventilator associated pneumonia
    • Sepsis
  • Clinical evidence
  • About us
    • Purpose, vision and mission
    • Business model
    • History
  • Media
    • Press releases
    • Updates
  • Contact
    • Head office
    • Whistleblower
  • Menu iconInvestors
Get more information